Source: https://www.federalregister.gov/documents/2009/09/29/E9-23459/notice-of-availability-of-environmental-assessment-and-finding-of-no-significant-impact-for-license
Timestamp: 2017-08-18 14:53:31
Document Index: 166869072

Matched Legal Cases: ['art 51', 'art 51', 'art 30', 'art 20', 'art 20', 'art 20', 'art 51']

Federal Register :: Notice of Availability of Environmental Assessment and Finding of No Significant Impact for License Amendment to Byproduct Materials License No. 29-30152-01, for Unrestricted Release of the Ligand Pharmaceuticals Facility in Cranbury, NJ
74 FR 49897
NRC-2009-0430
E9-23459
https://www.federalregister.gov/d/E9-23459 https://www.federalregister.gov/d/E9-23459
The U.S. Nuclear Regulatory Commission (NRC) is considering the issuance of a license amendment to Byproduct Materials License No. 29-30152-01. This license is held by Ligand Pharmaceuticals (the Licensee), for its Ligand Pharmaceuticals facility (the Facility), located at 3000 Eastpark Boulevard in Cranbury, New Jersey. Issuance of the amendment would authorize release of the East Wing of the Facility for unrestricted use. The Licensee requested this action in a letter dated July 29, 2009. The NRC has prepared an Environmental Assessment (EA) in support of this proposed action in accordance with the requirements of Title 10, Code of Federal Regulations (CFR), Part 51 (10 CFR Part 51). Based on the EA, the NRC has concluded that a Finding of No Significant Impact (FONSI) is appropriate with respect to the proposed action. The amendment will be issued to the Licensee following Start Printed Page 49898the publication of this FONSI and EA in the Federal Register.
The proposed action would approve the Licensee's July 29, 2009, license amendment request, resulting in release of the East Wing of the Facility for unrestricted use. License No. 29-30152-01 was issued on July 21, 1994, pursuant to 10 CFR Part 30, and has been amended periodically since that time. This license authorized the Licensee to use unsealed byproduct material for purposes of conducting research and development activities on laboratory bench tops and in hoods.
The Facility contains approximately 58,000 square feet of office space, laboratories, and hallways. The Facility is located in a research park in a commercial area. Within the East Wing of the Facility, use of licensed materials was confined to nine laboratories and one room used for waste storage.
In winter 2009, the Licensee ceased licensed activities and initiated a survey and decontamination of the East Wing of the Facility. Based on the Licensee's historical knowledge of the site and the conditions of the East Wing of the Facility, the Licensee determined that only routine decontamination activities, in accordance with their NRC-approved, operating radiation safety procedures, were required. The Licensee was not required to submit a decommissioning plan to the NRC because worker cleanup activities and procedures are consistent with those approved for routine operations. The Licensee conducted surveys of the East Wing of the Facility and provided information to the NRC to demonstrate that it meets the criteria in Subpart E of 10 CFR Part 20 for unrestricted release.
The Licensee has ceased conducting licensed activities in the East Wing of the Facility, and seeks the unrestricted use of the East Wing of its Facility.
The historical review of licensed activities conducted in the East Wing of the Facility shows that such activities involved use of the following radionuclides with half-lives greater than 120 days: Hydrogen-3, carbon-14, and calcium-45. Prior to performing the final status survey, the Licensee conducted decontamination activities, as necessary, in the areas of the East Wing of the Facility affected by these radionuclides.
The Licensee conducted a final status survey between April 13 and May 1, 2009. This survey covered Laboratories 110, 120, 130, 140, 150, 175, 185, and 187; the waste room; and the connecting hallways. The final status survey report was attached to the Licensee's amendment request dated July 29, 2009. The Licensee elected to demonstrate compliance with the radiological criteria for unrestricted release as specified in 10 CFR 20.1402 by using the screening approach described in NUREG-1757, “Consolidated NMSS Decommissioning Guidance,” Volume 2. The Licensee used the radionuclide-specific derived concentration guideline levels (DCGLs), developed there by the NRC, which comply with the dose criterion in 10 CFR 20.1402. These DCGLs define the maximum amount of residual radioactivity on building surfaces, equipment, and materials, and in soils, that will satisfy the NRC requirements in Subpart E of 10 CFR Part 20 for unrestricted release. The Licensee's final status survey results were below these DCGLs and are in compliance with the As Low As Reasonably Achievable (ALARA) requirement of 10 CFR 20.1402. The NRC thus finds that the Licensee's final status survey results are acceptable.
Based on its review, the staff has determined that the affected environment and any environmental impacts associated with the proposed action are bounded by the impacts evaluated by the “Generic Environmental Impact Statement in Support of Rulemaking on Radiological Criteria for License Termination of NRC-Licensed Nuclear Facilities” (NUREG-1496) Volumes 1-3 (ML042310492, ML042320379, and ML042330385). The staff finds there were no significant environmental impacts from the use of radioactive material in the East Wing of the Facility. The NRC staff reviewed the docket file records and the final status survey report to identify any non-radiological hazards that may have impacted the environment surrounding the East Wing of the Facility. No such hazards or impacts to the environment were identified. The NRC has identified no other radiological or non-radiological activities in the area that could result in cumulative environmental impacts.
The NRC staff finds that the proposed release of the East Wing of the Facility for unrestricted use is in compliance with 10 CFR 20.1402. Although the Licensee will continue to perform licensed activities at other parts of the Facility, the Licensee must ensure that this decommissioned area does not become recontaminated. Before the license can be terminated, the Licensee will be required to show that the entire Facility, including previously-released areas, complies with the radiological criteria in 10 CFR 20.1402. Based on its review, the staff considered the impact of the residual radioactivity in the East Wing of the Facility and concluded that the proposed action will not have a significant effect on the quality of the human environment.
Due to the largely administrative nature of the proposed action, its environmental impacts are small. Therefore, the only alternative the staff considered is the no-action alternative, under which the staff would leave things as they are by simply denying the amendment request. This no-action alternative is not feasible because it conflicts with 10 CFR 30.36(d), requiring that decommissioning of byproduct material facilities be completed and approved by the NRC after licensed activities cease. The NRC's analysis of the Licensee's final status survey data confirmed that the East Wing of the Facility meets the requirements of 10 CFR 20.1402 for unrestricted release. Additionally, denying the amendment request would result in no change in current environmental impacts. The environmental impacts of the proposed action and the no-action alternative are therefore similar and the no-action alternative is accordingly not further considered.
NRC provided a draft of this Environmental Assessment to the New Jersey Department of Environmental Protection for review on August 10, 2009. On September 10, 2009, the New Jersey Department of Environmental Protection responded by letter. The State agreed with the conclusions of the EA, and otherwise had no comments.
The NRC staff has determined that the proposed action is of a procedural nature, and will not affect listed species or critical habitat. Therefore, no further consultation is required under Section 7 of the Endangered Species Act. The Start Printed Page 49899NRC staff has also determined that the proposed action is not the type of activity that has the potential to cause effects on historic properties. Therefore, no further consultation is required under Section 106 of the National Historic Preservation Act.
[1] Letter dated July 29, 2009 with the “Decommissioning Survey for Ligand Pharmaceuticals” ML092170692;
[2] NUREG-1757, “Consolidated NMSS Decommissioning Guidance;”
[3] Title 10, Code of Federal Regulations, Part 20, Subpart E, “Radiological Criteria for License Termination;”
[4] Title 10, Code of Federal Regulations, Part 51, “Environmental Protection Regulations for Domestic Licensing and Related Regulatory Functions;” and
[5] NUREG-1496, “Generic Environmental Impact Statement in Support of Rulemaking on Radiological Criteria for License Termination of NRC-Licensed Nuclear Facilities.”
[FR Doc. E9-23459 Filed 9-28-09; 8:45 am]